August 15th 2025, 7:00pm
Intensive chemotherapy improved survival in patients with accelerated and blast phase myeloproliferative neoplasms, with Venclexta showing no clear benefit.
August 15th 2025, 5:00pm
A diagnosis of breast cancer isn’t something most people would think of as a teacher, but sometimes important lessons come to us in unexpected ways.
August 15th 2025, 4:00pm
Cancer treatments can speed up aging in survivors, according to research, which can contribute to a person's risk for conditions like heart disease.
August 15th 2025, 3:00pm
The FDA has granted fast track designation to HLD-0915 for metastatic castration-resistant prostate cancer.
August 15th 2025, 1:00pm
The accelerated approval of Modeyso for diffuse midline glioma with an H3 K27M mutation, is a step in the right direction but more work remains.
August 14th 2025, 9:00pm
Breast cancer survivor and researcher LaShae Rolle studies how individualized strength training during chemo boosts physical, mental and emotional health.
August 14th 2025, 8:00pm
Dr. Jim Omel, who was diagnosed with multiple myeloma in 1997, explained how the treatment landscape has changed over nearly 30 years.
August 14th 2025, 7:00pm
More than half of patients with myelofibrosis and low platelets treated with Vonjo saw platelets rise 58% and hemoglobin levels improve.
August 14th 2025, 5:00pm
Living with stage 4 cancer taught me the power of community; connecting with others provides guidance, support, and hope in an often-lonely journey.
August 14th 2025, 4:00pm
Dr. Jacob Sands explained that he believes patients should be having more personalized, nuanced conversations with their oncologists.
Top Lung Cancer Stories from October: Insights, and Patient Journeys
How AI Can Put Patients at the Center of Cancer Care
FDA Approves Darzalex Faspro in High-Risk Smoldering Multiple Myeloma
Sharing More Than 25 Years of Brain Tumor Survival